← Leaderboards
Lucy Mary Golden
University Of Colorado Denver
$2,735,092
Attributed
$2,735,092
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,862,197 · 4
By mechanism
R01$2,497,500 · 2
P30$1,127,105 · 1
P42$237,592 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Cheryl Lynne Ackert-Bicknell$7,745,724
- Rebecca Leanne Smathers McCullough$2,500,061
- Anna Peljto$470,850
- Mary Cm Weiser-Evans$14,403,734
- Evgenia Dobrinskikh$660,618
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsLiverPrimary Carcinoma Of The Liver CellsCirrhosisFibrosisChronic Liver DiseaseHepaticPathologyCytokineInsightPreventInflammatoryLiver DiseasesBaseDisease ModelLiver FibrosisMediatingHepatocyteMonocyteGenesLiver TransplantationCharacteristicsHepatic Stellate CellMacrophage
Grant awards (9)
Research Project 1: Mechanisms of PFAS hepatotoxicity: A Multi-Omics Study Using Human Liver Spheroids$237,592
P42 · FY2025 · ES · contact PI
Innate Immunity, Cholesterol, and NASH Pathogenesis$371,250
R01 · FY2023 · DK · contact PI
Innate Immunity, Cholesterol, and NASH Pathogenesis$371,250
R01 · FY2022 · DK · contact PI
USC Research Center for Liver Disease$1,127,105
P30 · FY2020 · DK · contact PI
Human Group 2 Innate Lympohocyte Cell (ILC2) populations contribute to Hepatic Fibrosis$334,125
R01 · FY2019 · DK · contact PI
Human Group 2 Innate Lympohocyte Cell (ILC2) populations contribute to Hepatic Fibrosis$371,250
R01 · FY2018 · DK · contact PI
Human Group 2 Innate Lymphocyte Cell (ILC2) populations contribute to Hepatic Fibrosis$349,875
R01 · FY2017 · DK · contact PI
Human Group 2 Innate Lymphocyte Cell (ILC2) populations contribute to Hepatic Fibrosis$349,875
R01 · FY2016 · DK · contact PI
Human Group 2 Innate Lymphocyte Cell (ILC2) populations contribute to Hepatic Fibrosis$349,875
R01 · FY2015 · DK · contact PI